Hospital Readmissions Necessary Evil or Preventable Target for Quality Improvement

被引:46
作者
Brown, Erin G. [1 ]
Burgess, Debra [1 ]
Li, Chin-Shang [2 ]
Canter, Robert J. [1 ]
Bold, Richard J. [1 ]
机构
[1] UC Davis Canc Ctr, Div Surg Oncol, Sacramento, CA 95817 USA
[2] UC Davis Sch Med, Dept Publ Hlth Sci, Div Biostat, Sacramento, CA USA
基金
美国国家卫生研究院;
关键词
cancer; hospital readmissions; NCI designation; volume-outcome relationship; PANCREATIC RESECTION; SURGERY PATIENTS; PANCREATICODUODENECTOMY; COMPLICATIONS; COST; MORTALITY; PATIENT; LENGTH; IMPACT; STAY;
D O I
10.1097/SLA.0000000000000923
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: To evaluate readmission rates and associated factors to identify potentially preventable readmissions. Background: The decision to penalize hospitals for readmissions is compelling health care systems to develop processes to minimize readmissions. Research to identify preventable readmissions is critical to achieve these goals. Methods: We performed a retrospective review of University HealthSystem Consortium database for cancer patients hospitalized from January 2010 to September 2013. Outcome measures were 7-, 14-, and 30-day readmission rates and readmission diagnoses. Hospital and disease characteristics were evaluated to evaluate relationships with readmission. Results: A total of 2,517,886 patients were hospitalized for cancer treatment. Readmission rates at 7, 14, and 30 days were 2.2%, 3.7%, and 5.6%, respectively. Despite concern that premature hospital discharge may be associated with increased readmissions, a shorter initial length of stay predicted lower readmission rates. Furthermore, high-volume centers and designated cancer centers had higher readmission rates. Evaluating institutional data (N = 2517 patients) demonstrated that factors associated with higher readmission rates include discharge from a medical service, site of malignancy, and emergency primary admission. When examining readmission within 7 days for surgical services, the most common readmission diagnoses were infectious causes (46.3%), nausea/vomiting/dehydration (26.8%), and pain (6.1%). Conclusions: A minority of patients after hospitalization for cancer-related therapy are readmitted with potentially preventable conditions such as nausea, vomiting, dehydration, and pain. However, most factors associated with readmission cannot be modified. In addition, high-volume centers and designated cancer centers have higher readmission rates, which may indicate that readmission rates may not be an appropriate marker for quality improvement.
引用
收藏
页码:583 / 591
页数:9
相关论文
共 27 条
  • [1] Factors Influencing Readmission After Pancreaticoduodenectomy A Multi-Institutional Study of 1302 Patients
    Ahmad, Syed A.
    Edwards, Michael J.
    Sutton, Jeffrey M.
    Grewal, Sanjeet S.
    Hanseman, Dennis J.
    Maithel, Shishir K.
    Patel, Sameer H.
    Bentram, David J.
    Weber, Sharon M.
    Cho, Clifford S.
    Winslow, Emily R.
    Scoggins, Charles R.
    Martin, Robert C.
    Kim, Hong Jin
    Baker, Justin J.
    Merchant, Nipun B.
    Parikh, Alexander A.
    Kooby, David A.
    [J]. ANNALS OF SURGERY, 2012, 256 (03) : 529 - 537
  • [2] [Anonymous], READM RED PROGR
  • [3] Outcomes of Pancreaticoduodenectomy Where Should We Focus Our Efforts on Improving Outcomes?
    Brown, Erin G.
    Yang, Anthony
    Canter, Robert J.
    Bold, Richard J.
    [J]. JAMA SURGERY, 2014, 149 (07) : 694 - 699
  • [4] The Evolving Importance of Readmission Data to the Practicing Surgeon
    Brown, Russell E.
    Qadan, Motaz
    Martin, Robert C. G., II
    Polk, Hiram C., Jr.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (04) : 558 - 560
  • [5] Forecasting Hospital Readmission After Surgery Data and the Hard-to-Measure Role of Culture
    DiBrito, Sandra
    Makary, Martin A.
    [J]. JAMA SURGERY, 2014, 149 (05) : 445 - 446
  • [6] Hospital readmission after pancreaticoduodenectomy
    Emick, Dawn M.
    Riall, Taylor S.
    Cameron, John. L.
    Winter, Jordan M.
    Lillemoe, Keith D.
    Coleman, JoAnn
    Sauter, Patricia K.
    Yeo, Charles J.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (09) : 1243 - 1252
  • [7] Complications nearly double the cost of care after pancreaticoduodenectomy
    Enestvedt, C. Kristian
    Diggs, Brian S.
    Cassera, Maria A.
    Hammill, Chet
    Hansen, Paul D.
    Wolf, Ronald F.
    [J]. AMERICAN JOURNAL OF SURGERY, 2012, 204 (03) : 332 - 338
  • [8] Readmission After Pancreatic Resection is not an Appropriate Measure of Quality
    Gawlas, Irmina
    Sethi, Monica
    Winner, Megan
    Epelboym, Irene
    Lee, James L.
    Schrope, Beth A.
    Chabot, John A.
    Allendorf, John D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) : 1781 - 1787
  • [9] Readmission After Colectomy for Cancer Predicts One-Year Mortality
    Greenblatt, David Yu
    Weber, Sharon M.
    O'Connor, Erin S.
    LoConte, Noelle K.
    Liou, Jinn-Ing
    Smith, Maureen A.
    [J]. ANNALS OF SURGERY, 2010, 251 (04) : 659 - 669
  • [10] What Is the Inpatient Cost of Hospital Complications or Death After Lobectomy or Pneumonectomy?
    Handy, John R., Jr.
    Denniston, Kelly
    Grunkemeier, Gary L.
    Wu, Ying Xing
    [J]. ANNALS OF THORACIC SURGERY, 2011, 91 (01) : 234 - 238